Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G > C as the most common mutation

被引:41
|
作者
Liu, Xiao [1 ]
Wang, Zhaoxia [1 ]
Jin, Weina [1 ]
Lv, He [1 ]
Zhang, Wei [1 ]
Que, Chengli [2 ]
Huang, Yu [3 ]
Yuan, Yun [1 ]
机构
[1] Peking Univ, Dept Neurol, Hosp 1, Beijing 100034, Peoples R China
[2] Peking Univ, Resp Dept Internal Med, Hosp 1, Beijing 100034, Peoples R China
[3] Peking Univ, Hlth Sci Ctr, Dept Med Genet, Sch Basic Med Sci, Beijing 100191, Peoples R China
来源
BMC MEDICAL GENETICS | 2014年 / 15卷
关键词
GENOTYPE-PHENOTYPE CORRELATION; DIAGNOSIS; SPECTRUM; IDENTIFICATION; FREQUENCY;
D O I
10.1186/s12881-014-0141-2
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Pompe disease is an autosomal recessive lysosomal glycogen storage disorder that has been reported in different ethnic populations which carry different common mutations of the acid alpha-glucosidase (GAA) gene. The GAA mutation pattern in mainland Chinese patients with late-onset Pompe disease is still not well understood. Methods: We presented the clinical and genetic characteristics of 27 mainland Chinese late-onset Pompe patients from 24 families. Results: GAA mutation analysis revealed 26 different mutations, including 10 that were novel. The allelic frequency of c.2238G > C (p.W746C) was found to be 27.08% in this patient group. Respiratory dysfunction was diagnosed in 10 of 11 patients who underwent pulmonary function evaluation, although only four required ventilator support at night. Conclusions: Our findings indicate that c.2238G > C (p.W746C) is the most common mutation in mainland Chinese late-onset Pompe patients, as observed in Taiwanese patients. The novel mutations identified in this study expand the genetic spectrum of late-onset Pompe disease, and the prevalence of respiratory dysfunction highlights the importance of monitoring pulmonary function in late-onset Pompe patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Deferoxamine mesylate improves splicing and GAA activity of the common c.-32-13T>G allele in late-onset PD patient fibroblasts
    Buratti, Emanuele
    Peruzzo, Paolo
    Braga, Luca
    Zanin, Irene
    Stuani, Cristiana
    Goina, Elisa
    Romano, Maurizio
    Giacca, Mauro
    Dardis, Andrea
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 20 : 227 - 236
  • [22] A genomic approach to mutation analysis of holocarboxylase synthetase gene in three Chinese patients with late-onset holocarboxylase synthetase deficiency
    Tang, NLS
    Hui, J
    Yong, CKK
    Wong, LTK
    Applegarth, DA
    Vallance, HD
    Law, LK
    Fung, SLM
    Mak, TWL
    Sung, YM
    Cheung, KL
    Fok, TF
    CLINICAL BIOCHEMISTRY, 2003, 36 (02) : 145 - 149
  • [23] LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease
    Infante, J
    Rodríguez, E
    Combarros, O
    Mateo, I
    Fontalba, A
    Pascual, J
    Oterino, A
    Polo, JM
    Leno, C
    Berciano, J
    NEUROSCIENCE LETTERS, 2006, 395 (03) : 224 - 226
  • [24] A family with multiple members affected by late-onset Pompe disease due to the R224W(670C>T) mutation:: Potential candidates for enzyme replacement therapy?
    Vondracek, P.
    Hermanova, M.
    Oslejskova, H.
    Soukalova, J.
    Gaillyova, R.
    Malinova, V.
    Poupetova, H.
    Halley, D.
    Van der Ploeg, A.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 793 - 793
  • [25] Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G>A
    Wang, Zhi-Qiang
    Chen, Xue-Jiao
    Murong, Shen-Xing
    Wang, Ning
    Wu, Zhi-Ying
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2011, 89 (06): : 569 - 576
  • [26] Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in the southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G>A
    Wang, Zhi-Qiang
    Chen, Xue-Jiao
    Murong, Shen-Xing
    Wang, Ning
    Wu, Zhi-Ying
    NEUROSCIENCE RESEARCH, 2011, 71 : E195 - E195
  • [27] A newly identified c.1824_1828dupATACG mutation in exon 13 of the GAA gene in infantile-onset glycogen storage disease type II (Pompe disease)
    Omid Aryani
    Masoumeh Dehghan Manshadi
    Mahdi Tondar
    Elham Khalili
    Behnam Kamalidehghan
    Fatemeh Ahmadipour
    Somayeh Fani
    Massoud Houshmand
    Molecular Biology Reports, 2014, 41 : 6211 - 6214
  • [28] A newly identified c.1824_1828dupATACG mutation in exon 13 of the GAA gene in infantile-onset glycogen storage disease type II (Pompe disease)
    Aryani, Omid
    Manshadi, Masoumeh Dehghan
    Tondar, Mahdi
    Khalili, Elham
    Kamalidehghan, Behnam
    Ahmadipour, Fatemeh
    Fani, Somayeh
    Houshmand, Massoud
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (09) : 6211 - 6214
  • [29] Clinical feature and outcome of late-onset cobalamin C disease patients with neuropsychiatric presentations: a Chinese case series
    Wang, Sheng-jun
    Yan, Chuan-zhu
    Wen, Bing
    Zhao, Yu-ying
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 549 - 555
  • [30] Plasma globotriaosylsphingosine (lysoGb3) could be a biomarker for Fabry disease with a Chinese hotspot late-onset mutation (IVS4+919G>A)
    Liao, Hsuan-Chieh
    Huang, Yu-Hsiu
    Chen, Yann-Jang
    Kao, Shu-Min
    Lin, Hsiang-Yu
    Huang, Chun-Kai
    Liu, Hao-Chuan
    Hsu, Ting-Rong
    Lin, Shuan-Pei
    Yang, Chia-Feng
    Fann, Cathy S. J.
    Chiu, Pao-Chin
    Hsieh, Kai-Sheng
    Fu, Yun-Ching
    Ke, Yu-Yuan
    Lin, Ching-Yuang
    Tsai, Fuu-Jen
    Wang, Chung-Hsing
    Chao, Mei-Chyn
    Yu, Wen-Chung
    Chiang, Chuan-Chi
    Niu, Dau-Ming
    CLINICA CHIMICA ACTA, 2013, 426 : 114 - 120